TSPO and Alzheimer disease: TSPO positron emission tomography (PET) is widely used as a measure of microglial activation [88], and TSPO ligands reduce neuroinflammation and gliosis [87] and protect against neuropathology in mouse models of AD [89] and tauopathy [90].